Standardization of Non-academic Center Surgical Morbidity and Mortality Conference: a Type I Hybrid Implementation Non-clinical Trial.

May 19, 2023 updated by: Lacey LaGrone, Poudre Valley Health System
  • Specific Aim 1: Determine impact of standardized morbidity and mortality (M&M) toolkit on provider satisfaction with, and perceived impact of, M&M conference.
  • Specific Aim 2: Identify barriers and facilitators to toolkit implementation.

Study Overview

Detailed Description

Design:

- Pre-, post- intervention mixed-methods trial.

  • Inclusion:

    o M&M conference attendees at enrolled level II and III trauma centers, inclusive of trainees, administrative staff, providers.

  • Exclusion:

    • Age < 18
    • Anticipated attendance at <= one M&M conference at study site.
  • Intervention:

    • Brief didactic regarding evidence base for M&M conferences.
    • Sequential deployment of standardized M&M toolkit
  • Standardized slide deck
  • Code of conduct
  • Conference planning checklist
  • Case documentation form
  • Recruitment:

    o Pre/post survey:

  • M&M attendees will be invited to scan a QR code made available at the beginning of an M&M conference, and to take 5 minutes to fill the associated survey if they consent.

    o Semi-structured interview:

  • The research coordinator contact information will be emailed to M&M listserv, requesting interested parties contact them to schedule an interview.
  • Data collection

    o Specific Aim 1:

  • Pre/post 10 question digital, anonymous mixed-methods (one free text question) survey

    • Demographics collected: occupation (surgeon / app / non-surgeon physician / other), years in practice (<10, 10-20, >20)

  • Observation of M&M to capture:

    • # of attendees

    • # of cases presented at each conference
    • # of cases which include literature review
    • # of cases which include determination of recommended system change (just culture..?)

      • Specific Aim 2:
  • Three, six and nine months after initial toolkit deployment we will conduct semi-structured interviews regarding implementation barriers and facilitators.

    • Interviews will be conducted in-person and audio-recorded.
    • Interview guide will be modified to emphasize opportunities for improvement identified in initial quantitative data collection.

      • For instance, if baseline data suggests case referral is the primary problem, will triage discussion of this portion of the M&M process higher and ask additional detail regarding perceived means of improvement.
      • The interview guide scope will not change from that submitted, the emphasis will pivot as described.
    • Data analysis will be ongoing, and results of each interview set will be used to inform adaptation of implementation approach.
  • Consent

    o Would like to submit a request for waiver of written consent and inclusion of information sheet in survey with confirmation of understanding but without signature, collection of names.

  • Timeline

    o Baseline survey and observational data collection Feb - April 2022, intervention deployment March - May 2022, follow-up data collection Feb - April 2023.

  • Study Sites o Northern Colorado M&M (Greeley, Longs Peak, Poudre Valley, Medical Center of the Rockies)

Study Type

Interventional

Enrollment (Actual)

28

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Colorado
      • Loveland, Colorado, United States, 80538
        • Medical Center of the Rockies

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • M&M conference attendees at enrolled level II and III trauma centers, inclusive of trainees, administrative staff, providers.

Exclusion Criteria:

  • Age < 18
  • Anticipated attendance at <= one M&M conference at study site.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention
o Sequential deployment of standardized M&M toolkit at a regional M&M conference.
  • Standardized slide deck
  • Code of conduct
  • Conference planning checklist
  • Case documentation form

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Perception of effective M&M conference
Time Frame: one year
Participant endorses having seen a change at their institution attributable to a discussion at an M&M conference
one year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 24, 2022

Primary Completion (Actual)

February 6, 2023

Study Completion (Actual)

February 6, 2023

Study Registration Dates

First Submitted

March 9, 2022

First Submitted That Met QC Criteria

March 9, 2022

First Posted (Actual)

March 18, 2022

Study Record Updates

Last Update Posted (Actual)

May 22, 2023

Last Update Submitted That Met QC Criteria

May 19, 2023

Last Verified

May 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Surgery

Clinical Trials on Morbidity and mortality conference toolkit

Subscribe